PACTR202311887239866尚未招募1 期
Phase I Clinical Trial for Evaluation of Rosmarinus officinalis, Thymus schimperi, Eucalyptus globulus, Cymbopogon citratus and Lavandula angustifolia on healthy human skin
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Healthy volunteers without skin diseases or any other diseases (acute or chronic) from both sexes
- •Available for follow-up observations during the clinical trial period
- •Willing to avoid using topical or systemic steroids or antihistamines for at least 7 days prior to trial initiation and during the duration of the trial
排除标准
- •A history of adverse reactions to adhesive tape
- •Participants with hypersensitive skin; skin abnormalities, such as severe acne, erythema, or telangiectasia at the test site
- •Participants who use the same or similar cosmetics (or pharmaceuticals) on the test site within three months
- •Those who have undergone a skin peeling or having wrinkles removed within six months of the interview
研究者
相似试验
尚未招募
不适用
A phase I clinical trial to study the safety of treatment with Tipifarnib (ZARNESTRA) combined with Bortezomib (VELCADE) in patients with myelodysplastic syndrome (MDS)myelodysplasiamyelodysplastic syndroom10018865NL-OMON30154niversitair Medisch Centrum Sint Radboud18
已完成
1 期
Mesenchymal Stem Cells Transplantation in newly diagnosed Type-1 Diabetes PatientsDiabetes.Insulin-dependent diabetes mellitusIRCT2016070428786N1Royan Institute20
进行中（未招募）
1 期
Phase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of children and young adult with relapsed/refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/refractory B-cell Acute Lymphoblastic LeukemiaCTIS2023-508420-36-00Ospedale Pediatrico Bambino Gesu'24
进行中（未招募）
不适用
Phase II clinical study for the therapy of cystic fibrosis patients with aspecific mutatioCystic fibrosis patients with F508del-CFTR in homozygous or compound heterozygous with Class I or II mutationsEUCTR2013-001258-82-ITEuropean Institute for Cystic Fibrosis Research (IERFC)
尚未招募
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N3Hamedan University of Medical Sciences40